Acurx Pharmaceuticals Company Insiders
| ACXP Stock | USD 1.15 0.01 0.88% |
Acurx Pharmaceuticals employs about 4 people. The company is managed by 3 executives with a total tenure of roughly 10 years, averaging almost 3.0 years of service per executive, having 1.33 employees per reported executive. Discussion of Acurx Pharmaceuticals' management performance can provide insight into the enterprise performance.
Acurx |
Acurx Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.3222) % which means that it has lost $1.3222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4694) %, meaning that it created substantial loss on money invested by shareholders. Acurx Pharmaceuticals' management efficiency ratios could be used to measure how well Acurx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/29/2024, Return On Tangible Assets is likely to drop to -1.99. In addition to that, Return On Capital Employed is likely to drop to -3.28. At this time, Acurx Pharmaceuticals' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 11/29/2024, Change To Liabilities is likely to grow to about 1.5 M, while Total Current Liabilities is likely to drop slightly above 1.8 M.As of 11/29/2024, Common Stock Shares Outstanding is likely to drop to about 11.8 M. In addition to that, Net Loss is likely to drop to about (11.4 M)
Acurx Pharmaceuticals Workforce Comparison
Acurx Pharmaceuticals LLC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 565. Acurx Pharmaceuticals maintains roughly 4.0 in number of employees contributing less than 1% to equities under Health Care industry.
Acurx Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acurx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acurx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Acurx Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Acurx Pharmaceuticals Notable Stakeholders
An Acurx Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acurx Pharmaceuticals often face trade-offs trying to please all of them. Acurx Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acurx Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| CPA Esq | President CoFounder | Profile | |
| CPA CPA | CoFounder, Sec | Profile | |
| Robert DeLuccia | CoFounder Chairman | Profile |
About Acurx Pharmaceuticals Management Performance
The success or failure of an entity such as Acurx Pharmaceuticals LLC often depends on how effective the management is. Acurx Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acurx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acurx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.89) | (1.99) | |
| Return On Capital Employed | (3.12) | (3.28) | |
| Return On Assets | (1.89) | (1.99) | |
| Return On Equity | (3.12) | (3.28) |
Acurx Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Acurx Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acurx Pharmaceuticals within its industry.Acurx Pharmaceuticals Manpower Efficiency
Return on Acurx Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.6M | |
| Net Loss Per Executive | 4.9M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 1.6M |
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.